BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30548484)

  • 21. Effect of EphA7 Silencing on Proliferation, Invasion and Apoptosis in Human Laryngeal Cancer Cell Lines Hep-2 and AMC-HN-8.
    Xiang C; Lv Y; Wei Y; Wei J; Miao S; Mao X; Gu X; Song K; Jia S
    Cell Physiol Biochem; 2015; 36(2):435-45. PubMed ID: 25968442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.
    Shuang Y; Li C; Zhou X; Huang Y; Zhang L
    Oncol Rep; 2017 Oct; 38(4):2155-2165. PubMed ID: 28791411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
    Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
    Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor mutations in Chinese patients with laryngeal squamous cell carcinoma.
    Wang DS; Lai HC; Huang JM
    Acta Otolaryngol; 2014 Jun; 134(6):631-5. PubMed ID: 24646139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of DCUN1D1 in laryngeal squamous cell carcinoma and its inhibiting effect on TU-177 cells after interfered by RNA.
    Liu J; Shuang Y; Li C; Zhou X; Huang Y; Zhang L
    Clin Exp Pharmacol Physiol; 2018 May; 45(5):461-466. PubMed ID: 29164666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
    World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
    Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
    Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
    Mann JE; Smith JD; Birkeland AC; Bellile E; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Moyer JS; Wolf GT; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
    Cancer Immunol Immunother; 2019 Feb; 68(2):213-220. PubMed ID: 30361882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished expression of S100A2, a putative tumour suppressor, is an independent predictive factor of neck node relapse in laryngeal squamous cell carcinoma.
    Almadori G; Bussu F; Galli J; Rigante M; Lauriola L; Michetti F; Maggiano N; Schafer BW; Heizmann CW; Ranelletti FO; Paludetti G
    J Otolaryngol Head Neck Surg; 2009 Feb; 38(1):16-22. PubMed ID: 19344608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mutation and expression of MUS81 gene in laryngeal squamous cell carcinoma].
    Li C; Wang S; Yuan H; Li W; Li Z; Li X; Guo X; Li F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):560-5. PubMed ID: 18841572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
    Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
    PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of p53 and Bcl-2 protein expression in the recurrent laryngeal and pharyngeal squamous cell carcinoma.
    Rashad UM; Hussein MR; Algizawy SM
    Am J Otolaryngol; 2011; 32(3):210-4. PubMed ID: 20434805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DIAPH2 alterations increase cellular motility and may contribute to the metastatic potential of laryngeal squamous cell carcinoma.
    Kostrzewska-Poczekaj M; Byzia E; Soloch N; Jarmuz-Szymczak M; Janiszewska J; Kowal E; Paczkowska J; Kiwerska K; Wierzbicka M; Bartochowska A; Ustaszewski A; Greczka G; Grenman R; Szyfter K; Giefing M
    Carcinogenesis; 2019 Oct; 40(10):1251-1259. PubMed ID: 30793164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular genetics of laryngeal cancer.
    Loyo M; Pai SI
    Otolaryngol Clin North Am; 2008 Aug; 41(4):657-72, v. PubMed ID: 18570952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD47 is a Potential Target for the Treatment of Laryngeal Squamous Cell Carcinoma.
    Yang C; Gao S; Zhang H; Xu L; Liu J; Wang M; Zhang S
    Cell Physiol Biochem; 2016; 40(1-2):126-136. PubMed ID: 27855370
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Gong XY; Chen HB; Zhang LQ; Chen DS; Li W; Chen DH; Xu J; Zhou H; Zhao LL; Song YJ; Xiao MZ; Deng WL; Qi C; Wang XR; Chen X
    Front Immunol; 2022; 13():920253. PubMed ID: 35911687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
    Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
    Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.